Oxidative stress in HIV positive children
Keywords:HIV, Malondialdehyde, Oxidative stress
Background: The objective is to assess oxidative stress by measuring the concentration of malondialdehyde in HIV positive children and compare it with normal children (not suffering from any disease) of the same age group.
Methods: In this prospective comparative study, we analysed malondialdehyde in 80 HIV positive children in the age group of 6-12 yrs from lower socio-economic strata and compared the values with 85 normal children not infected by any disease, of the same age group and similar socio-economic strata at L.T.M.M. College. Estimation of Malondialdehyde was carried out by using the method of SADASIVUDU by thiobarbituric acid reaction.
Results: The level of Malondialdehyde was significantly higher in HIV positive children than in controls.
Conclusions: The increased levels of Malondialdehyde confirm the involvement of oxidative stress in the pathophysiology of this infection in children
John W. Sleasman JW, Goodenov MM, PhD.HIV-1 infection. J Allergy Clin Immunol. 2003;111(2):S583-91.
Mueller BU, Pizzo PA. Pediatric Human Immunodeficiency Virus Infections, In: AIDS: Biology, Diagnosis, Treatment and Prevention. 4th ed. 1997:443-457.
Ananthnarayan, Panikker CK. Human Immunodeficiency Virus: AIDS. In: Text Book of Microbiology. 6th ed. 1995:539-556.
Jareno EJ, Bosch-Morell F, Fernandez-Delgado R, Donat J, Romero FJ. Serum malondialdehyde in HIV seropositive children. Free Radical Biol Med. 1998;24(3):503-6.
Hosein S. HIV and antioxidants, Treatment Update. 1997;7(7)
Lemens C, Sterrit C. Antioxidants, Oxidative stress and Nac. Gaymens Health Crisis. Treatment issues. 1994;7:11-12.
Mc Dermid JM, Lalonde RG, Donald KG. Associations between dietary antioxidant intake and oxidative stress in HIV-seropositive and HIV-seronegative men and women. J AIDS, 2002;29(2):158-63.
Baruchel S, Wainberg MA. The role of oxidative stress in disease progression in individuals infected by the humam immunodeficiency virus. J Leukoc Biol. 1992;52:111-4.
Favier A. Oxidative stress in human diseases, Ann. Pharm Fr. 2006;64(6):390-6.
Clarkson M, Thompson HS. Antioxidants: what role do they play in physical activity and health. Am J Clin Nutr. 2000;72:637S-46S
Yu BP. Cellular defences against damage from reactive oxygen species. Physiol Rev. 1994;74:139-62.
Romero FJ, Bosch-Morell F, Romer MJ. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect. 1998;106950;1229-34.
Sonneborg A, Carlin G, Akerlund B. Increased production of malondialdehyde in patients with HIV infection. Scand J Infect Dis. 1988;20(3):287-90.
Marnett LJ. Oxyradicals, lipid peroxidation and DNA damage. Toxicology. 2002;181/182: 219-22.
Gutteridge M. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995;96:693-702.
Sasikala M, Subramanyam C, Sadasivudu B. Early oxidative change in low density lipoproteins during progressive chronic renal failure. Indian J Clin Biochem. 1999;14(2):176-83.
Delmas-Beauvieux MC, Peauchant E, Couchouron A. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients. Am J Clin Nutr. 1996;64:101-7.
Allard JP, Aghdassi E, Chau J, Salit I, Walmsley S. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr. 1998;67:143-7.
Gil L, Martinez G, Gonzalez I. Contribution to Characterization of oxidative stress in HIV/AIDS patients. Pharmaco Res. 2003;47(3):217-24.